Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

SPIRE 1 & 2: A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability of PF-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events. Atherosclerotic Cardiovascular Disease (CVD)

Projekt: Typer af projekterProjekt

Vis graf over relationer
Periode01/07/2015 → …

ID: 45616202